Scrutinizer''s Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Ltd filed the Scrutinizer's Report for its 22nd AGM held on September 30, 2025, at its registered office in Mumbai. Two ordinary resolutions were put to vote via physical ballot paper: (1) adoption of the audited financial statements for the financial year ended March 31, 2025, and (2) re-appointment of Mr. Hemant Chandravadan Bhagat (DIN: 00233530) as Director, who retires by rotation. Both resolutions received 5,281,056 shares in favour (69.99% of valid votes cast) from 9 members, with zero votes against and zero invalid/abstained votes. The Scrutinizer, Amit Dharmani & Associates (Company Secretaries), confirmed both resolutions were passed with the requisite majority.
This is a routine procedural filing confirming shareholder approval of standard AGM items. With no dissenting votes, the results reflect smooth governance and uncontested director continuity. No material impact on the stock is expected.